LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing
1 other identifier
interventional
600
1 country
1
Brief Summary
This is a prospective, colonoscopist-blinded, randomized, controlled study with consecutive outpatients undergoing colonoscopy in Taipei Medical University Hospital.The study would comply with the standards of the Declaration of Helsinki and current ethical guidelines. It have been approval by Taipei Medical University Institutional Review Board.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedAugust 13, 2019
July 1, 2017
5 years
December 22, 2016
August 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adequate bowel preparation
total Ottawa score \<6 or Boston bowel preparation scale ≥ 6
Day 1
Secondary Outcomes (2)
colon polyp detection rate
Day 1
cecal intubation rate
Day 1
Study Arms (2)
300 Randomized to re-education group
EXPERIMENTALLINE re-education of colon preparation
300 Randomized to control group
NO INTERVENTIONeducation of colon preparation 1 time in hospital
Interventions
Eligibility Criteria
You may qualify if:
- Outpatients aged 18-80 years undergoing colonoscopy who will provide written informed consent will be eligible for participation in the study.
You may not qualify if:
- history of colorectal surgery;
- severe colonic stricture or obstructing tumor;
- uncooperative mental status;
- significant ileus;
- known or suspected bowel obstruction or perforation;
- severe chronic renal failure (creatinine clearance \<30 ml/min);
- severe congestive heart failure (New York Heart Association class III or IV);
- uncontrolled hypertension (systolic blood pressure \>180 mm Hg, diastolic blood pressure\>100 mm Hg);
- liver cirrhosis;
- toxic colitis or megacolon;
- active gastrointestinal bleeding;
- dehydration or disturbance of electrolytes;
- pregnancy or lactation; and
- hemodynamically unstable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Medical University hospital
Taipei, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Yu Kao, M.D.
Taipei Medical University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- All patients will be instructed not to tell colonoscopists, nurses and investigators before, during and after the procedure about their preparation method and when they receive instructions.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2016
First Posted
August 13, 2019
Study Start
June 1, 2015
Primary Completion
June 1, 2020
Study Completion
June 1, 2021
Last Updated
August 13, 2019
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share